News Release

Future Science Group launches Journal of 3-D Printing in Medicine

Business Announcement

Future Science Group

<i>Journal of 3-D Printing in Medicine</i>

image: This is the cover image. view more 

Credit: Future Science Group

Future Science Group (FSG) is excited to announce the launch of the Journal of 3D Printing in Medicine, a new peer-reviewed online and print publication dedicated to addressing all aspects of medical 3D printing. The journal is the latest addition to the internationally recognized Future Medicine portfolio and is supported by a multidisciplinary, international editorial board comprising leading researchers and opinion leaders from academia and industry.

The Journal of 3D Printing in Medicine encompasses all aspects of bioprinting and 3D printing of relevance to medicine and provides a forum for research, review and commentary in a fast-moving, inter-disciplinary research area. Journal of 3D Printing in Medicine presents key data and opinions as they emerge. The coverage spans many fields, including biomedical engineering, medical devices, surgical guides, tissue engineering and biomaterials, as well as covering regulatory and safety issues, patents and health economics.

Editorial Director Laura Dormer commented: "We are delighted to launch this new journal in such an exciting emerging field. 3D printing is set to have a huge impact on the future of healthcare, and I look forward to reading about these exciting developments in the journal."

This issue is opened with a foreword from the Editor-in-Chief Dietmar Hutmacher and contains a variety of articles, including Editorials by Michael Gelinsky and David Williams discussing where the direction of future focus in 3D printing research may be heading. In a Short Communication, Gelinsky also explores extrusion-based 3D printing. Daniel Thomas, Zita Jessop and Iain Whitaker's Methodology article describe the production of 3D bioprinted ear structures for the use of reconstructive surgery. The characteristics and production ease of 3D printed, drug-loaded implants to treat alcohol misuse is presented in Michael Davies's research article. There are also two review articles with Margaret Prendergast looking at the current and future potential of biofabrication bioinks; and coverage of the role of IT in 3D bioprinting from Jorge Vicente Lopes da Silva. Finally there is also an enlightening interview with Pankaj Chandak where he discusses the role of 3D printing of model kidneys for use in surgical planning.

###

Journal of 3D Printing in Medicine is the partner journal of the site 3DMedNet, an online network covering the whole field of 3D printing in medicine and healthcare. 3DMedNet will provide exclusive journal content and can be accessed here: https://www.3dmednet.com/

The full contents list for the first issue as well as articles published ahead of print can be viewed at: http://www.futuremedicine.com/loi/3dp

Call for papers

The editorial office is now actively soliciting contributions of original research, reviews and perspective pieces for the Journal of 3D Printing in Medicine. The journal team is also always looking to publish shorter pieces to spark the interest of our readers such as Editorials, Opinions, Commentaries, Interviews, Research Highlights, Conference Scenes and Company/Institutional/Organizational Profiles. Unsolicited article proposals are also always welcome, so if you are interested in contributing to the journal, please contact the Commissioning Editor, Sonia Mannan at s.mannan@futuremedicine.com

About Future Science Group

Founded in 2001, the London-based FSG is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. Please see http://www.future-science-group.com and http://www.future-science.com/ for more information.

For further information on the Journal of 3D Printing in Medicine, please contact: Sonia Mannan, Commissioning Editor, Future Science Group, s.mannan@futuremedicine.com


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.